Drugs that contain Metformin Hydrochloride; Pioglitazone Hydrochloride
1. Drug name - ACTOPLUS MET
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9101660 | TAKEDA PHARMS USA | Solid preparation |
Jan, 2027
(4 years from now) | |
| US9320714 | TAKEDA PHARMS USA | Tablet |
Feb, 2029
(6 years from now) | |
Treatment: NA
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 500MG;EQ 15MG BASE | TABLET;ORAL | Prescription |
| 850MG;EQ 15MG BASE | TABLET;ORAL | Prescription |
2. Drug name - ACTOPLUS MET XR
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8470368 | TAKEDA PHARMS USA | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
Sep, 2023
(11 months from now) | |
| US8668931 | TAKEDA PHARMS USA | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
Sep, 2023
(11 months from now) | |
| US9060941 | TAKEDA PHARMS USA | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
Sep, 2023
(11 months from now) | |
| US7785627 | TAKEDA PHARMS USA | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
Jul, 2026
(3 years from now) | |
| US7959946 | TAKEDA PHARMS USA | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
Jul, 2026
(3 years from now) | |
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 1GM;EQ 15MG BASE | TABLET, EXTENDED RELEASE;ORAL | Discontinued |
| 1GM;EQ 30MG BASE | TABLET, EXTENDED RELEASE;ORAL | Discontinued |
availability in other generic markets.
Click on the highlighted region to filter.